This is a Cannibidiol study where the FDA were so comfortable with the safety aspect that they allowed participants as young as 12 to be included.
The results weren't stellar but I can't see that they were bad either. They are progressing to Phase 3 application so what is the drama? I've bought more and am thinking about another trip to the well.
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-90
-
- There are more pages in this discussion • 561 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $660.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 37.5¢ | 35.0¢ | $2.529M | 6.961M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 151367 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 128287 | 10 |
View Market Depth
| Last trade - 13.43pm 15/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |